Lung cancer biomarkers and uses thereof
US11221340B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 30, 2018 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Apr 21, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B40/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose lung cancer or permit the differential diagnosis of pulmonary nodules as benign or malignant. In another aspect, methods are provided for diagnosing lung cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 18, Table 20, or Table 21, wherein the individual is classified as having lung cancer, or the likelihood of the individual having lung cancer is determined, based on the at least one biomarker value.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.